扩散加权MRI异质性分析用于鼻咽癌诱导化疗一周期后早期预测和评估微观结构变化
研究纳入10例接受诱导化疗的鼻咽癌患者,于化疗前、中、后行扩散加权成像,比较转移性淋巴结内治疗中与基线的ADC一阶直方图参数,并用判别分析组合治疗前ADC参数区分完全缓解与部分缓解组,结果显示部分异质性参数在化疗一周期后显著变化,治疗前Txt5Energy是正确分类完全缓解与部分缓解的最佳参数。
要点
- 鼻咽癌诱导化疗一周期后转移性淋巴结Mean与Txt1Mean显著升高(p=0.048和0.015)。
- Txt5Energy在化疗一周期后显著降低(p=0.002)。
- 治疗前Txt5Energy是正确分类完全缓解与部分缓解的最佳参数。
核心结论
- 从转移性淋巴结ADC图提取的异质性指标,在诱导化疗前后,可作为诱导化疗反应的补充指标。
研究设计与样本
- 研究纳入10例接受诱导化疗的鼻咽癌患者,于诱导化疗前、中、后行扩散加权成像,比较转移性淋巴结治疗中与基线的一阶ADC直方图参数,并采用判别分析组合治疗前ADC参数以区分完全缓解与部分缓解组。
诊断标准与关键数值
- 诱导化疗一周期后转移性淋巴结Mean较基线显著升高(p=0.048)。
- 诱导化疗一周期后转移性淋巴结Txt1Mean较基线显著升高(p=0.015)。
- 诱导化疗一周期后转移性淋巴结Txt5Energy较基线显著降低(p=0.002)。
- 治疗前ADC参数判别分析中,Txt5Energypre是正确分类完全缓解与部分缓解患者的最佳参数,其后依次为Txt9Percentile75pre、Txt1Meanpre和Txt2Standard Deviationpre。
临床应用与阅片要点
- 作者认为,从转移性淋巴结ADC图提取的异质性指标在诱导化疗前后可作为诱导化疗反应的补充指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate whether the pretreatment apparent diffusion coefficient (ADC) heterogeneity parameters and their alterations, after one cycle of induction chemotherapy, can be used as reliable markers of treatment response to induction chemotherapy in patients with nasopharyngeal cancer.
MATERIALS AND METHODS: Ten patients were recruited and received induction chemotherapy (IC). Diffusion-weighted imaging was performed prior to, during, and after IC. The first-order ADC histogram parameters at the intra-treatment time-point were compared to the baseline time-point in the metastatic lymph nodes (LNs). Some ADC pretreatment parameters were combined with each other, employing discriminant analysis to achieve a feasible model to separate the complete response (CR) from the partial response (PR) groups.
RESULTS: For ten patients, significant rise in Mean and Txt1Mean (p = 0.048 and 0.015, respectively) was observed in the metastatic nodes following one cycle of IC. Txt5Energy significantly decreased (p = 0.002). Discriminant analysis on pretreatment parameters illustrated that Txt5Energypre was the best parameter to use to correctly classify CR and PR patients. This was followed by Txt9Percentile75pre, Txt1Meanpre, and Txt2Standard Deviationpre.
CONCLUSIONS: Our results suggest that heterogeneity metrics extracted from ADC-maps in metastatic lymph nodes, before and after IC, can be used as supplementary IC response indicators.
引用
- Beigi M, Kazerooni AF, Safari M, et al. Heterogeneity analysis of diffusion-weighted MRI for prediction and assessment of microstructural changes early after one cycle of induction chemotherapy in nasopharyngeal cancer patients. Radiol Med. 2017. PMID: 28914416. doi:10.1007/s11547-017-0808-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。